Clinical and Experimental Pediatrics

Original Article

Oncology

Allogeneic stem-cell transplantation following chimeric antigen receptor T-cell therapy for treatment of relapsed/refractory hematologic malignancy in children and young adults: a systematic review and meta-analysis

Ghea Mangkuliguna, Edi Setiawan Tehuteru, Reganedgary Jonlean, Nicholas Adrianto, Stella Kallista

Clin Exp Pediatr. 2025;68(9):712-721. Published online July 4, 2025

Web of Science 1 Crossref 1

Question: Does consolidative allogeneic stem cell transplantation (allo-SCT) after chimeric antigen receptor (CAR) T-cell therapy improve outcomes of children and young adult patients with relapsed/refractory hematologic malignancies?
Finding: The meta-analysis showed reduced relapse rates and favorable survival trends with allo-SCT despite low evidence quality.
Meaning: Consolidative allo-SCT after CAR T-cell therapy may enhance survival; however, further clinical studies are needed.

DOI: https://doi.org/10.3345/cep.2025.00031

Full text
PubReader
ePub
PDF

Cited By 60	Prevalence of anxiety, depression, and stress among parents of neonates admitted to neonatal intensive care unit: a systematic review and meta-analysis
Cited By 39	Metabolic complications of obesity in children and adolescents
Cited By 37	Community-acquired pneumonia in children: updated perspectives on its etiology, diagnosis, and treatment
Cited By 34	Microplastic and human health with focus on pediatric well-being: a comprehensive review and call for future studies
Cited By 34	Global burden of asthma among children and adolescents with projections to 2050: a comprehensive review and forecasted modeling study

Author index